Surgical treatment of symptomatic epilepsy in patients with brain cavernomas


  • Vitaliy Tsymbaliuk Restorative Neurosurgery Department, Romodanov Neurosurgery Institute, Kiev, Ukraine
  • Orest Tsimeyko Emergency Department of Vascular Neurosurgery, Romodanov Neurosurgery Institute, Kiev, Ukraine
  • Leonid Yakovenko Department of Neurosurgical Pathology of Head and Neck Vessels, Romodanov Neurosurgery Institute, Kiev, Ukraine
  • Mykhaylo Kostiuk Department of Neurosurgical Pathology of Head and Neck Vessels, Romodanov Neurosurgery Institute, Kiev, Ukraine
  • Kostyantyn Kostiuk Department of Functional Neurosurgery, Romodanov Neurosurgery Institute, Kiev, Ukraine



symptomatic epilepsy, brain cavernoma, topectomy


Introduction. Epileptic seizures are one of the most common clinical manifestations of brain cavernomas. The purpose of study is to assess the efficiency of symptomatic epilepsy surgical treatment in patients with cerebral cavernomas.

Methods. The study included 22 patients with brain cavernomas caused symptomatic epilepsy. Patients were divided on two groups: I group consists 8 patients with cavernomas in the temporal lobe, II group consists 14 patients with extratemporal lesion’s localization. In all patients microsurgical resection of cavernomas was performed, 3 patients underwent additional anterior temporal lobectomy. Follow-up was from 10 months to 3,5 years.

Results. In I group 5 (62.5%) patients became seizure-free or have rare seizures, in 3 (37,5%) cases seizure frequency reduced slightly or did not change. Control for seizures was most effective in patients who underwent topectomy with additional anterior temporal lobectomy. In group II seizure control or significant seizure reduction was achieved in 7 (50%) patients, in other 7 (50%) — seizure frequency reduced slightly or did not change.

Conclusion. Surgical strategy of patients with symptomatic epilepsy associated with cavernomas should focus on the lesion resection with additional excision of the hemosiderin-stained tissue. In temporal cavernomas such surgery should be supplemented by anterior temporal lobectomy.


1. Voigt K, Yaşargil MG. Cerebral cavernous haemangiomas or cavernomas. Incidence, pathology, localization, diagnosis, clinical features and treatment. Review of the literature and report of an unusual case. Neurochirurgia (Stuttg). 1976 Mar;19(2):59-68. [PubMed]

2. Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T. Natural history of intracranial cavernous malformations. J Neurosurg. 1995;83(1):56-9. [CrossRef] [PubMed]

3. Rigamonti D, Hadley M, Drayer B, Johnson PC, Hoenig-Rigamonti K, Knight JT, Spetzler RF. Cerebral Cavernous Malformations. New Engl J Med. 1988;319(6):343-7. [CrossRef] [PubMed]

4. Bertalanffy H, Benes L, Miyazawa T, Alberti O, Siegel A, Sure U. Cerebral cavernomas in the adult: review of the literature and analysis of 72 surgically treated patients. Neurosurg Rev. 2002;25(1-2):1-53. [CrossRef] [PubMed]

5. Siegel A, Andermann E, Badhwar A, Rouleau G, Wolford G, Andermann F, Hess K. Anticipation in familial cavernous angioma: a study of 52 families from International Familial Cavernous Angioma Study. The Lancet. 1998;352(9141):1676-7. [CrossRef]

6. Lobato R, Perez C, Rivas J, Cordobes F. Clinical, radiological, and pathological spectrum of angiographically occult intracranial vascular malformations. J Neurosurg. 1988;68(4):518-31. [CrossRef] [PubMed]

7. Williamson A, Patrylo P, Lee S, Spencer D. Physiology of human cortical neurons adjacent to cavernous malformations and tumors. Epilepsia. 2003;44(11):1413-9. [CrossRef] [PubMed]

8. Menzler K, Chen X, Thiel P, Iwinska-Zelder J, Miller D, Reuss A, Hamer HM, Reis J, Pagenstecher A, Knake S, Bertalanffy H, Rosenow F, Sure U. Epileptogenicity of cavernomas depends on (archi-) cortical localization. Neurosurgery. 2010;67(4):918-24. [CrossRef] [PubMed]

9. Menzler, K., Thiel, P., Hermsen, A., Chen, X., Benes, L., Miller, D., Sure, U., Knake, S. and Rosenow, F. The role of underlying structural cause for epilepsy classification: Clinical features and prognosis in mesial temporal lobe epilepsy caused by hippocampal sclerosis versus cavernoma. Epilepsia. 2011;52(4):707-711. [CrossRef]

10. Josephson C, Leach J, Duncan R, Roberts R, Counsell C, Al-Shahi Salman R. Seizure risk from cavernous or arteriovenous malformations: Prospective population-based study. Neurology. 2011;76(18):1548-54. [CrossRef] [PubMed]

11. Al-Shahi Salman R. The outlook for adults with epileptic seizure(s) associated with cerebral cavernous malformations or arteriovenous malformations. Epilepsia. 2012;53:34-42. [CrossRef] [PubMed]

12. Awad I, Jabbour P. Cerebral cavernous malformations and epilepsy. Neurosurg Focus. 2006;21(1):1-9. [CrossRef] [PubMed]

13. Kim W, Stramotas S, Choy W, Dye J, Nagasawa D, Yang I. Prognostic factors for post-operative seizure outcomes after cavernous malformation treatment. J Clin Neurosci. 2011;18(7):877-80. [CrossRef] [PubMed]

14. Baumann C, Acciarri N, Bertalanffy H Devinsky O, Elger CE, Lo Russo G, Cossu M, Sure U, Singh A, Stefan H, Hammen T, Georgiadis D, Baumgartner RW, Andermann F, Siegel AM. Seizure Outcome after Resection of Supratentorial Cavernous Malformations: A Study of 168 Patients. Epilepsia. 2007;48(3):559-63. [CrossRef] [PubMed]

15. Stavrou I, Baumgartner C, Frischer J, Trattnig S, Knosp E. Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients Neurosurgery. 2008;63(5):888-97. [CrossRef] [PubMed]

16. Chang E, Gabriel R, Potts M, Garcia P, Barbaro N, Lawton M. Seizure characteristics and control after microsurgical resection of supratentorial cerebral cavernous malformations Neurosurgery. 2009;65(1):31-8. [CrossRef] [PubMed]

17. Yeon J, Kim J, Choi S, Seo D, Hong S, Hong S. Supratentorial cavernous angiomas presenting with seizures: Surgical outcomes in 60 consecutive patients. Seizure. 2009;18(1):14-20. [CrossRef] [PubMed]

18. Wieser H, Blume W, Fish D e Goldensohn E, Hufnagel A, King D, Sperling MR, Lüders H, Pedley TA; Commission on Neurosurgery of the International League Against Epilepsy (ILAE). Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia. 2001;42(2):282-286. [CrossRef] [PubMed]

19. Mintser OP, Voronenko YuV, Vlasov VV. Obroblennya klinichnykh i eksperymentalʹnykh danykh u medytsyni: navch. posibnyk [Treatment of clinical and experimental data in medicine; a tutorial]. Kiev: Vyshcha shkola; 2003. Ukrainian.

20. Stefan H, Hammen T. Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol Scand. 2004;110(6):393-7. [CrossRef] [PubMed]

21. Van Gompel J, Marsh W, Meyer F, Worrell G. Patient-assessed satisfaction and outcome after microsurgical resection of cavernomas causing epilepsy. Neurosurg Focus. 2010;29(3):E16. [CrossRef]

22. Rocamora R, Mader I, Zentner J, Schulze-Bonhage A. Epilepsy surgery in patients with multiple cerebral cavernous malformations. Seizure. 2009;18(4):241-5. [CrossRef] [PubMed]

23. Van Gompel J, Rubio J, Cascino G, Worrell G, Meyer F. Electrocorticography-guided resection of temporal cavernoma: is electrocorticography warranted and does it alter the surgical approach? J Neurosurg. 2009;110(6):1179-85. [CrossRef] [PubMed]

24. Yang I, Barbaro N. Advances in the radiosurgical treatment of epilepsy. Epilepsy Curr. 2007;7(2):31-35. [CrossRef] [PubMed]

25. Regis J, Bartolomei F, Kida Y, Kobayashi T, Vladyka V, Liscàk R, Forster D, Kemeny A, Schröttner O, Pendl G. Radiosurgery for epilepsy associated with cavernous malformation: retrospective study in 49 patients. Neurosurgery. 2000;47(5):1091-7. [CrossRef] [PubMed]

26. Kim M, Pyo S, Jeong Y, Lee S, Jung Y, Sim J. Gamma knife surgery for intracranial cavernous hemangioma. J Neurosurg. 2005;102(suppl):102-106. [CrossRef] [PubMed]

27. Shih Y, Pan D. Management of supratentorial cavernous malformations: craniotomy versus gammaknife radiosurgery. Clin Neurol Neurosurg. 2005;107(2):108-12. [CrossRef] [PubMed]



How to Cite

Tsymbaliuk, V., Tsimeyko, O., Yakovenko, L., Kostiuk, M., & Kostiuk, K. (2013). Surgical treatment of symptomatic epilepsy in patients with brain cavernomas. Ukrainian Neurosurgical Journal, (3), 25–29.



Original articles